1681. Optimal Cutoff Age for Predicting Mortality Associated with Differentiated Thyroid Cancer.
Kim SJ1, Myong JP2, Suh H3, Lee KE1, Youn YK1.
PLoS One. 2015 Jun 23;10(6):e0130848. doi: 10.1371/journal.pone.0130848. eCollection 2015.Link
1680. Aberrant Epigenetic Modifications of LPHN2 Function as a Potential Cisplatin-specific Biomarker for Human Gastrointestinal Cancer.
Jeon MS1,2, Song SH1, Yun J1,2, Kang JY1,2, Kim HP1, Han SW1,3, Kim TY1,2,3.
Cancer Res Treat. 2015 Sep 22. doi: 10.4143/crt.2015.153. [Epub ahead of print]Link
1679. Reduced cohesin destabilizes high-level gene amplification by disrupting pre-replication complex bindings in human cancers with chromosomal instability.
Yun J1, Song SH2, Kang JY1, Park J2, Kim HP1, Han SW3, Kim TY4.
Life Sci. 2015 Jan 1;120:39-47. doi: 10.1016/j.lfs.2014.10.014. Epub 2014 Oct 31.Link
1674. Taurine Chloramine Stimulates Efferocytosis Through Upregulation of Nrf2-Mediated Heme Oxygenase-1 Expression in Murine Macrophages: Possible Involvement of Carbon Monoxide.
Kim W1, Kim HU1, Lee HN1, Kim SH1, Kim C2, Cha YN2, Joe Y3, Chung HT3, Jang J1, Kim K1, Suh YG1, Jin HO4, Lee JK4, Surh YJ1,5,6.
1673. Human umbilical cord blood-derived mesenchymal stem cells improve functional recovery through thrombospondin1, pantraxin3, and vascular endothelial growth factor in the ischemic rat brain.
Park HW, Moon HE, Kim HS, Paek SL, Kim Y, Chang JW, Yang YS, Kim K, Oh W, Hwang JH, Kim JW, Kim DG, Paek SH.